The Independent Patient Advocate Organization

  • Bill C-64 An Act Respecting Pharmacare
  • CML & COVID-19 Important information
  • What is the CML Society
    • Who we are
      • The Patient Advisory Board
    • What we do
  • What is CML
    • The Story of Gleevec – Articles and Videos
  • Treatments
    • Access
    • Living well
    • Clinical Trials
  • Knowledge and Empowerment
  • Our Key Innovations for CML Patients
  • Related links
  • Contact us
  • Current Focus – Sustainable Drug Access & Treatment Monitoring
    • Patented Medicines Pricing Review Board – Announcement

Bosulif Conditionally Approved in Canada – Approuve Conditionnellement

Health Canada CONDITIONALLY approves BOSULIF – a new medication for chronic myelogenous leukemia
Approval provides new treatment option for Canadians suffering from rare cancer

SANTÉ CANADA APPROUVE CONDITIONNELLEMENT L’EMPLOI DE BOSULIF – UN NOUVEAU MÉDICAMENT CONTRE LA LEUCÉMIE MYÉLOÏDE CHRONIQUE
Les Canadiens bénéficient ainsi d’une nouvelle option de traitement pour un cancer rare 

Comments are closed .

  • Topics
    • Bill C-64 An Act Respecting Pharmacare
    • CML & COVID-19 Important information
    • What is the CML Society
      • Who we are
        • The Patient Advisory Board
      • What we do
    • What is CML
      • The Story of Gleevec – Articles and Videos
    • Treatments
      • Access
      • Living well
      • Clinical Trials
    • Knowledge and Empowerment
    • Our Key Innovations for CML Patients
    • Related links
    • Contact us
    • Current Focus – Sustainable Drug Access & Treatment Monitoring
      • Patented Medicines Pricing Review Board – Announcement
    • Bill C-64 An Act Respecting Pharmacare
    • CML & COVID-19 Important information
    • What is the CML Society
      • Who we are
        • The Patient Advisory Board
      • What we do
    • What is CML
      • The Story of Gleevec – Articles and Videos
    • Treatments
      • Access
      • Living well
      • Clinical Trials
    • Knowledge and Empowerment
    • Our Key Innovations for CML Patients
    • Related links
    • Contact us
    • Current Focus – Sustainable Drug Access & Treatment Monitoring
      • Patented Medicines Pricing Review Board – Announcement
  • Recent Posts / updates to this website
    • Recent Posts/ updates to our website
  • Register to receive our newsletter
    sending...
    You can also sign up for specific lists:
  • Search for items on this website
TOP

Powered by WordPress6.7.1 | Theme mxs